Tamoxifen and Toremifene are each a small molecule rather than a peptide.
| Comparison | Tamoxifen tamoxifen citrate · Nolvadex | Toremifene toremifene citrate · Fareston |
|---|---|---|
| How it works | How it works Tamoxifen does not lower estrogen. It changes what estrogen is able to do, and the answer differs by tissue. | How it works Toremifene has two separate actions, and only one of them is the point. |
| What it is | A breast cancer drug with a boxed warning, sold as a gyno fix. | A SERM with a boxed warning for a heart rhythm that can kill. |
| Status | FDA approvedFDA-approved | FDA approvedFDA-approved |
| Typical dose | 20–40 mg per day | 60 mg per day |
| How often | Daily | Daily |
| Stays active | Long, on the order of days | About 5 days |
| Dose comes from | FDA drug label | FDA drug label |
| Cycled? | Continuous, for years at a time in the trials FDA drug label | Continuous, until the disease progresses FDA drug label |
| What it does | ||
| Drug class | SERM (oral, not a peptide) | SERM (oral, not a peptide) |
| Used for | A long-established breast cancer drug used on the research market to prevent or reverse breast tissue growth in men. | A tamoxifen alternative sold on the research market for gynecomastia and post-cycle use, with a heart rhythm warning tamoxifen does not carry. |
| Receptors hit | — | — |
| Numbers | ||
| Full dose line | 20 up to 40 mg per day | 60 mg per day |
| Why that cycle | The risk-reduction indication runs 20 mg daily for five years without a break, and the adjuvant use runs for years. Nothing in the evidence base supports the short on-and-off courses used after an anabolic cycle, and nothing in it measures what those courses do. | The label runs it daily with no planned break and no defined stopping point other than disease progression. Nothing studies the short courses it is sold for. |
| Weight / effect | Not measured in a trial | Not measured in a trial |
| Chain length | Not disclosed | Not disclosed |
| Common vial | — | — |
| Before you start | ||
| Route | By mouth (oral) | By mouth (oral) |
| Do not use if | Taking warfarin, if the reason for treatment is breast cancer risk reduction A history of deep vein thrombosis or pulmonary embolism, in the same setting Pregnancy Known hypersensitivity to tamoxifen Banned in drug-tested sport | Congenital or acquired long QT syndrome Uncorrected low potassium or low magnesium Taking any other drug that prolongs the QT interval Taking a strong CYP3A4 inhibitor, and grapefruit juice should also be avoided Pregnancy Banned in drug-tested sport |
What people actually report
Tamoxifen
- It carries a boxed warning for uterine cancer, stroke and pulmonary embolism, and fatal cases of each have occurred.
- It acts like estrogen in the uterus while blocking it in breast tissue, which is where the cancer risk comes from.
- Cataract formation and cataract surgery were both more common on tamoxifen in the prevention trial.
- Banned in drug-tested sport at all times.
Stop and get help if
- Sudden shortness of breath, chest pain, or swelling and pain in one leg
- Weakness or numbness on one side, trouble speaking, or a sudden severe headache
Toremifene
- It carries a boxed warning for QT prolongation, which can lead to torsades de pointes and to fainting, seizure or death.
- The effect gets larger as the dose and the blood level go up.
- The label requires low potassium or low magnesium to be corrected before starting, and monitored afterwards.
- Banned in drug-tested sport at all times.
Stop and get help if
- Fainting, near-fainting, or a racing or pounding heartbeat
- A seizure
Side effects are what users and trials report most often, not a complete list. Anything sudden, spreading, or breathing-related is an emergency regardless of which compound caused it.
People also compare
This comparison does not cover cost, long-term safety, or how you personally will respond. Effect figures come from separate trials in different populations and are not always directly comparable to each other. Nothing here is medical advice or a recommendation to use any of these. Talk to a clinician about your own situation.